RECENT NEWS

Beckman Coulter Life Sciences has launched its new Valita Aggregation Pure assay, offering rapid, high-throughput protein aggregation detection and quantification, providing robust aggregation data in as little as 15 minutes.

On Monday 3 June, Synnovis - which provides pathology services to Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospitals NHS Trust - was the victim of a ransomware cyberattack. All of Synnovis’ IT systems were affected, resulting in interruptions to many of its pathology services.

bioMérieux inaugurated its new Rodolphe Mérieux Campus, in Bagno a Ripoli, Italy during May. The site includes a new R&D centre focusing on the fight against antimicrobial resistance, representing an investment of €9 million.

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to detect the presence of tiny amounts of cancer DNA left in the body following treatment for early breast cancer.

A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways, the Institute of Biomedical Science (IBMS) has announced.

DELFI Diagnostics, a developer of blood-based AI tests that deliver a new way to enhance cancer detection, has announced the publication of a study examining the potential of its blood-based cancer screening, ‘Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection’.

Sectra has launched a new diagnostic IT module for genomics within molecular pathology, developed in collaboration with the University of Pennsylvania Health System in the US.

The Council of the EU has formally adopted new rules updating the law on medical devices in order to help prevent shortages and ease the transition to greater transparency and access to information.

Sphere Fluidics, a provider of innovative microfluidics-based solutions for single-cell analysis and isolation, has announced the launch of Cyto-Cellect PLUS. The new assay provides a rapid and cost-effective solution to quantify IgG production in single cells.

eLabNext has launched its new Sample and Inventory System, following a comprehensive overhaul which has been driven by extensive customer feedback and the firm’s commitment to enhancing usability, functionality, and integration.

An inexpensive, accurate test that detects infections with the parasite Toxoplasma gondii can provide results within 30 minutes from a finger-prick in a doctor’s office or within an hour from a small blood sample tested in a local medical laboratory.

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS ‘matchmaking’ service to help find new life-saving treatments.

Digital pathology and AI firm Paige has announced the launch of a new service line based on its Foundation Models, including the world's largest multi-modal AI model in pathology and oncology.

The World Health Organization (WHO) has released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritisation. The list provides guidance on the development of new and necessary treatments to stop the spread of antimicrobial resistance (AMR).

INTEGRA Biosciences has released a new eBook providing a complete guide to next generation sequencing (NGS).

Bosch Healthcare Solutions has developed a PCR test for detecting Candida auris (C. auris) on the Vivalytic platform. The test is a global innovation now available for order from distribution partners including Randox Laboratories and R-Biopharm.

Jerusalem-based startup Salignostics, which develops and provides rapid tests based on saliva samples, has signed a cooperation agreement with ARC Innovation - the innovation arm of Sheba Medical Center. The agreement aims to develop a test for detecting oral cavity cancer based on saliva samples.

A joint study carried out by US health group Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes and advance individually tailored care has been published in Nature.

A study, presented at the 61st European Renal Association (ERA) Congress, has uncovered a significant breakthrough in the diagnosis and monitoring of kidney diseases associated with nephrotic syndrome.

A 'new era' in medical diagnostics and patient care in Dorset was celebrated as NHS staff and partners gathered recently, to witness patient Steve Hiorns officially open the state-of-the-art Dorset Pathology Hub.